Genetic aspects in Parkinson's disease by Goras, Dina
The 7th International Medical Congress for Students and Young Doctors 
 ____________________________________________________________________________________ 
 
212 
 
outlines, sometimes irregular thickening. Amielin nerve fibers are distinguished by the presence 
of a large number of varicosities.  
Conclusion. In conclusion, we can mention that, by studying the nervous structure of the brain's 
vascular system in the conditions of chronic and acute vascular pathology, changes were 
detected, which in fact denotes the presence of the reactive and destructive phenomena of the 
related nerve fibers. The reversible changes are also noted by the receiver in the reflexogenic 
areas of the vessels. 
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Introduction. Parkinson disease is a progressive disorder of the nervous system. The disorder 
affects several regions of the brain, especially an area called the substantia nigra that controls 
balance and movement. Although the etiology of Parkinson disease is still unclear, most cases 
are hypothesized to be due to a combination of genetic- 10% and environmental factors. 
Aim of the study. Evaluation of the genetic and environmental factors in etiopathogenesis of 
Parkinson's disease. Study of the molecular mechanisms involved in the etiology of PD; 
Evaluation of the major genes for higher risk of PD; Estimating the role of environmental and 
genetic factors in the onset, development and prognosis PD; Prospects survey prevention and 
treatment of PD. 
Materials and methods. Scientific articles review.  
Results. A total of 18 loci in various genes have now been proposed for PD. Mutations within 6 
of these loci (SNCA, LRRK2, PRKN, DJ1, PINK1, and ATP 13A2) are well-validated causes of 
familial parkinsonism. Inheritance is autosomal dominant for SNCA and LRRK2. Inheritance is 
autosomal recessive for PRKN, DJ1, PINK1, and ATP13A2. Stem cell therapy for Parkinson’s 
disease (Embryonic Stem Cells/ induced Pluripotent Stem Cells (iPSCs) that are adult cells (e.g. 
skin cells)) is a potential treatment for PD, because the most significant neuronal degeneration is 
site and type specific (ie, dopaminergic); the target area is well defined (ie, striatum); 
postsynaptic receptors are relatively intact. Gene therapy has distinct theoretical advantages over 
conventional treatment for Parkinson's disease as it might preserve or restore dopaminergic 
neurons through the use of growth factors or alternatively increase the availability of enzymes 
required for dopamine synthesis. 
Conclusions. Neurodegeneration in PD is due to three interrelated molecular mechanisms: 
changes oxiative, mitochondrial dysfunction and degradation of proteins affected. Major genes 
are involved in Parkinson disease: SNCA, LRRK2, PRKN, DJ1, PINK1, ATP13A2, GBA. 
Environmental and genetic factors play an important role in the onset, development and 
prognosis BP, and they can vary from one patient to another and will depend on the root cause. 
Perspentivele in prevention and treatment of PD are presimptomatic screening and gene therapy. 
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